Resources
Browse our resource collection and learn more about the evolving force behind Nordic Bioscience's success.
Fecal calprotectin is already an established biomarker for inflammatory bowel disease. But because conventional calprotectin is measured in fecal samples there is low patient compliance and high day-to-day variance resulting in low precision and accuracy.
Watch Joachim present our exciting biomarker data from Nordic Bioscience’s novel serum calprotectin assay for inflammatory bowel disease.
Search and find publications that we have published.
Please don't hesitate to contact us if you have any questions or other inquiries.
